Rusoma Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 11-07-2024
- Paid Up Capital ₹ 2.90 M
as on 11-07-2024
- Company Age 46 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 14.70 Cr
as on 11-07-2024
- Satisfied Charges ₹ 1.20 M
as on 11-07-2024
- Revenue 72.88%
(FY 2022)
- Profit 110.47%
(FY 2022)
- Ebitda 15.55%
(FY 2022)
- Net Worth 1.22%
(FY 2022)
- Total Assets 33.44%
(FY 2022)
About Rusoma Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 2.90 M.
The company currently has active open charges totaling ₹14.70 Cr. The company has closed loans amounting to ₹1.20 M, as per Ministry of Corporate Affairs (MCA) records.
Mahesh Sharma, Anand Sharma, Naman Sharma, and One other member serve as directors at the Company.
- CIN/LLPIN
U24230MH1978PTC020467
- Company No.
020467
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Jul 1978
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- LocationMumbai, Maharashtra
- Telephone
- Email Address
- Website
- Social Media
What products or services does Rusoma Laboratories Private Limited offer?
Rusoma Laboratories Private Limited offers a wide range of products and services, including IV Fluids, Dextrose Injection, Sodium Chloride Injection, Surgical & ICU Equipments, Dialysis Machine, Common Disease Medicines, Pharma Ingredients & Raw Materials, Pharmaceutical Excipients, Injectable Products, Sterile Water.
Who are the key members and board of directors at Rusoma Laboratories?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mahesh Sharma  | Director | 04-Jul-1978 | Current |
| Anand Sharma | Director | 04-Jul-1978 | Current |
| Naman Sharma | Director | 01-Apr-2008 | Current |
| Tapan Sharma | Director | 01-Apr-2008 | Current |
Financial Performance and Corporate Structure Insights of Rusoma Laboratories.
Rusoma Laboratories Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 72.88% increase. The company also saw a substantial improvement in profitability, with a 110.47% increase in profit. The company's net worth moved up by a moderate rise of 1.22%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rusoma Laboratories?
Unlock access to Rusoma Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Rumoya Healthcare LlpActive 5 years 5 monthsMahesh Sharma, Anand Sharma and 2 more are mutual person
- Agir Lifesciences Private LimitedActive 5 years 8 months
Mahesh Sharma and Tapan Sharma are mutual person
- Rusoma Healthcare Private LimitedActive 3 years 3 months
Mahesh Sharma and Tapan Sharma are mutual person
- Juror Analyticals & Research Private LimitedActive 8 years 7 months
Naman Sharma and Tapan Sharma are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 31 Jan 2024 | ₹1.10 Cr | Open |
Others Creation Date: 19 Mar 2022 | ₹1.61 Cr | Open |
Others Creation Date: 20 Feb 2020 | ₹5.80 M | Open |
How Many Employees Work at Rusoma Laboratories?
Unlock and access historical data on people associated with Rusoma Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rusoma Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rusoma Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
